Apellis Pharmaceuticals, Inc. 8-K SEC Filings

Filed On	Filing
14 May 2026	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +8 more
04 May 2026	8-K: Departure/Election of Directors or Officers; Compensation
31 Mar 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
02 Mar 2026	8-K: Departure/Election of Directors or Officers; Compensation
12 Jan 2026	8-K: Results of Operations and Financial Condition
01 Jul 2025	8-K: Entry into a Material Definitive Agreement
04 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
21 Apr 2025	8-K: Departure/Election of Directors or Officers; Compensation
13 Jan 2025	8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation
08 Aug 2024	8-K: Other Events
05 Jun 2024	8-K: Submission of Matters to a Vote of Security Holders
14 May 2024	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation
27 Feb 2024	8-K: Results of Operations and Financial Condition; Other Events
22 Jan 2024	8-K: Departure/Election of Directors or Officers; Compensation
08 Jan 2024	8-K: Results of Operations and Financial Condition
14 Dec 2023	8-K: Other Events
01 Dec 2023	8-K: Regulation FD Disclosure
01 Nov 2023	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement
05 Oct 2023	8-K: Results of Operations and Financial Condition
29 Aug 2023	8-K: Costs Associated with Exit or Disposal Activities; Other Events

Comments